查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462907

基因遞送技術市場，按模式、按應用、按方法、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Gene Delivery Technologies Market, By Mode, By Application, By Method, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年基因遞送技術市場規模為 39.18 億美元，2024 年至 2032 年CAGR為 14.5%。

基因傳遞技術市場-市場動態

加大新技術投入拉動市場需求

支持各種基因轉移技術的研究、開發和生產的行業資金和投資的增加進一步加速了收入的成長。目前，70% 的基因和細胞治療計劃使用病毒載體，這正在推動生物遞送技術的有機收入成長。為了滿足不斷成長的需求，營運公司正在進行大量投資，以提高病毒載體的生產能力。幾種革命性的基因修飾工具的引入促進了新基因傳遞系統的開發，這些工具簡化了科學界在基因組層面上概述疾病複雜本質的過程。正在進行的研究旨在創造適合臨床的病毒和非病毒載體，以最先進的藥物治療癌症、阿茲海默症和其他疾病等嚴重疾病，這也增加了市場的收入。

基因傳遞技術市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 14.5% 左右的CAGR成長

根據模式細分，生物細分市場預計將在預測期內主導市場

從應用細分來看，2023年基因治療佔最大市場佔有率

根據方法細分，Ex vivo 細分市場預計將在預測期內領先市場

按地區分類，北美是 2023 年的主要收入來源

基因傳遞技術市場-細分分析：

全球基因傳遞技術市場根據模式、應用、方法和地區進行細分。

根據模式，市場分為生物、化學和物理。由於 Yescarta 和 Kymriah 的巨大成功，生物領域預計將在預測期主導市場。自從第一個基於病毒載體的基因治療產品獲得批准以來，病毒載體引起了廣泛的關注。基於這些載體的研發項目數量呈指數級成長，證實了最終用戶認可病毒載體作為主要傳遞方式。

根據應用，市場分為基礎設施基因治療、細胞治療、疫苗和研究。基因療法在 2023 年佔據最大的市場佔有率，預計在預測期內將繼續保持相同的格局。該類別的收入產生是由於基因藥物的可接受性不斷提高以及由此導致的臨床研究活動數量的增加而推動的。全球基因治療產品核准率正在上升，這進一步推動了該領域的擴張。

根據方法的不同，業界將其分為Ex vivo、In vivo、In Vitro。體外部分預計將在預測期內引領市場，因為它具有許多優點，包括減少免疫原性反應以及在將細胞重新植入患者之前評估轉導效率的能力。其出色的轉導效率和其他品質使其成為研究環境中的熱門選擇。

基因傳遞技術市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美將在預測期內引領基因傳遞技術市場。在美國，正在進行大量臨床試驗來評估基因療法作為愛滋病毒/愛滋病、癌症和遺傳性疾病潛在治療方法的安全性和有效性。此外，參與基因傳遞技術生產和行銷的最大企業中有相當一部分的總部設在美國。該地區在基因傳遞技術方面的商業主導地位可歸因於幾個特徵。

基因遞送技術市場-競爭格局：

預計公共和私人投資者對基因傳遞技術日益成長的興趣將加速新公司進入市場。為了提高市場地位，領先公司還實施了一系列策略活動，包括許可、合作夥伴關係和併購。過去幾年，基因遞送技術業務發生了引人注目的併購。

最近的發展：

2022 年 9 月，全球基因治療領域的領導者 Orchard Therapeutics plc 和總部位於日本的全球專業製藥公司 (J-GSP) Kyowa Kirin Co., Ltd. 宣布，該公司利用最新的生物技術開發尖端醫療解決方案他們已達成最終協議，Kyowa Kirin 將收購Orchard Therapeutics。透過此次收購，Kyowa Kirin 將能夠最佳化 Libmeldy(R) 的價值，並有效加快 Orchard Therapeutics 下一代 MPS 項目的開發，以及其他早期研究計劃，包括額顳葉失智症 (FTD) 和克隆氏症的嚴重遺傳形式。此外，Kyowa Kirin 的技能、資源和基礎設施與Orchard Therapeutics 的尖端HSC 基因治療平台技術相結合，將促進許多有前途的生物製藥候選藥物的持續開發，這些候選藥物有可能在醫療保健領域提供變革價值，包括協和麒麟在自體免疫疾病和腫瘤學等治療領域和適應症方面擁有豐富的經驗。

目錄

第1章：基因傳遞技術市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 基因傳遞技術市場片段（按模式）
    • 基因傳遞技術市場片段（按應用）
    • 基因傳遞技術市場片段（依方法）
    • 按國家/地區分類的基因傳遞技術市場片段
    • 按地區分類的基因傳遞技術市場片段
  • 競爭洞察

第 3 章：基因傳遞技術主要市場趨勢

  • 基因傳遞技術市場促進因素
    • 市場促進因素的影響分析
  • 基因傳遞技術市場限制
    • 市場限制影響分析
  • 基因傳遞技術市場機會
  • 基因傳遞技術市場未來趨勢

第 4 章：基因傳遞技術產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：基因傳遞技術市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：基因傳遞技術市場格局

  • 2023 年基因傳遞技術市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：基因傳遞技術市場 - 按模式

  • 概述
    • 按模式分類的細分市場佔有率分析
    • 生物
      • 腺病毒
      • 逆轉錄病毒
      • 腺病毒
      • 慢病毒
      • 其他病毒
      • 非病毒性
    • 化學
    • 身體的

第 8 章：基因傳遞技術市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 基因治療
    • 細胞療法
    • 疫苗
    • 研究

第 9 章：基因傳遞技術市場 - 按方法

  • 概述
    • 按方法分類的細分市場佔有率分析
    • 離體
    • 體內
    • 體外

第 10 章：基因傳遞技術市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美基因傳遞技術主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模及預測（按模式）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按方法）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲基因傳遞技術主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按模式）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模與預測（按方法）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區基因傳遞技術主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模及預測（按模式）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模與預測（依方法）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲基因傳遞技術主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模及預測（按模式）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模與預測（按方法）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 基因傳遞技術中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按模式）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（依方法）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 基因傳遞技術產業

  • 競爭儀表板
  • 公司簡介
    • QIAGEN
    • Vectalys
    • Horizon Discovery Group Co.
    • OriGene Technologies, Inc.
    • Oxford Biomedica
    • SignaGen Laboratories
    • Thermo Fisher Scientific, Inc.
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • System Biosciences llc
    • Hoffmann-La Roche AG
    • Promega Corporation
    • Sirion-Biotech GmbH
    • Catalent Inc.

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2365

REPORT HIGHLIGHT

Gene Delivery Technologies Market size was valued at USD 3,918 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

The method of transferring foreign genetic material-such as DNA or RNA-into host cells is known as gene delivery. For gene delivery to cause gene expression, the host cell's genome must be reached. For gene delivery to be successful, the foreign gene delivery must stay stable inside the host cell and be able to either multiply on its own or integrate into the genome. To accomplish this, foreign DNA must be created as a component of a vector that is intended to infiltrate the target host cell and transfer the transgene to that cell's genome. Recombinant viruses and synthetic vectors (viral and non-viral) are the two types of vectors that are used to transfer genes.

Gene Delivery Technologies Market- Market Dynamics

Growing investment in new technologies to propel market demand

An increase in funding and investment in the industry that supports the research, development, and production of various techniques of gene transfer accelerates the growth in revenue even more. Currently, 70% of gene and cell therapy initiatives use viral vectors, which is driving organic revenue growth for biological delivery technologies. To meet the growing demand, the operational companies are making large investments to increase the capacity at which they can produce viral vectors. The development of new gene delivery systems has been facilitated by the introduction of several revolutionary tools for genetic modifications that have simplified the process by which the scientific community has outlined the intricate nature of disease at the genomic level. Ongoing research to create clinically appropriate vectors, both viral and non-viral, to cure crippling diseases like cancer, Alzheimer's disease, and others with state-of-the-art medicines, additionally increases the market's revenue.

Gene Delivery Technologies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on mode segmentation, the biological segment is expected to dominate the market over the forecast period

Based on the application segmentation, the Gene Therapy held the largest market share in 2023

Based on method segmentation, the Ex vivo segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

Gene Delivery Technologies Market- Segmentation Analysis:

The Global Gene Delivery Technologies Market is segmented based on Mode, Application, Method, and Region.

Based on the mode, the market is categorized into Biological, Chemical and Physical. The biological segment is expected to dominate the market over the forecast period due to Yescarta's and Kymriah's enormous success. Since the first viral vector-based gene therapy products were approved, viral vectors have attracted a lot of attention. End users' approval of viral vectors as the primary delivery modality has been confirmed by the exponential rise in the number of R&D programs based on these vectors.

Based on the application, the market is divided into Infrastructure Gene Therapy, Cell Therapy, Vaccines and Research. The Gene Therapy held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. The revenue generation in this category has been driven by the increasing acceptability of gene-based medicines and the resulting rise in the number of clinical research activities. Global gene therapy product approval rates are rising, which has further fueled the segment's expansion.

Based on the method, the industry is divided into Ex vivo, In vivo and In vitro. The Ex vivo segment is expected to lead the market over the projected period because of its many benefits, including reduced immunogenic reactions and the capacity to evaluate transduction efficiency before re-implantation of cells into the patient. Its excellent transduction efficiency and other qualities make it a popular choice in research environments.

Gene Delivery Technologies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the Gene Delivery Technologies market during the forecast period. In the United States, a significant number of clinical trials are being conducted to evaluate the safety and effectiveness of gene therapy as a potential treatment for HIV/AIDS, cancer, and genetic disorders. Additionally, a sizable portion of the largest businesses involved in the production and marketing of gene delivery technology have their headquarters in the United States. The region's commercial dominance in gene delivery technology can be attributed to several characteristics.

Gene Delivery Technologies Market- Competitive Landscape:

It is projected that the growing interest in gene delivery technologies among both public and private investors would hasten the entry of new firms into the market. To improve their market position, the leading companies are also implementing a number of strategic activities, including licensing, partnerships, and mergers and acquisitions. Notable mergers and acquisitions have taken place in the gene delivery technology business in the last few years.

Recent Developments:

In September 2022, Orchard Therapeutics plc, a leader in global gene therapy, and Kyowa Kirin Co., Ltd., a Japan-based global specialty pharmaceutical company (J-GSP) that develops cutting-edge medical solutions using the newest biotechnology, announced they have entered into a definitive agreement under which Kyowa Kirin will acquire Orchard Therapeutics. Through this acquisition, Kyowa Kirin will be able to optimize the value of Libmeldy(R) and effectively expedite the development of Orchard Therapeutics' next-generation MPS programs in addition to its other early research initiatives, which include frontotemporal dementia (FTD) and a severe genetic form of Crohn's disease. Additionally, the combination of Kyowa Kirin's skills, resources, and infrastructure with Orchard Therapeutics' cutting-edge HSC gene therapy platform technology will facilitate the ongoing development of a number of promising biopharmaceutical candidates with the potential to provide transformative value in medical care, including in therapeutic areas and indications like autoimmune diseases and oncology where Kyowa Kirin has extensive experience.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

QIAGEN

Vectalys

Horizon Discovery Group Co.

OriGene Technologies, Inc.

Oxford Biomedica

SignaGen Laboratories

Thermo Fisher Scientific, Inc.

Takara Bio Inc.

Bio-Rad Laboratories, Inc.

System Biosciences llc

Hoffmann-La Roche AG

Promega Corporation

Sirion-Biotech GmbH

Catalent Inc.

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY MODE- MARKET ANALYSIS, 2019 - 2032

  • Biological
  • Adenovirus
  • Retrovirus
  • AAV
  • Lentivirus
  • Other viruses
  • Non-viral
  • Chemical
  • Physical

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Gene Therapy
  • Cell Therapy
  • Vaccines
  • Research

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Ex vivo
  • In vivo
  • In vitro

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Gene Delivery Technologies Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Gene Delivery Technologies Market Snippet by Mode
    • 2.1.2.Gene Delivery Technologies Market Snippet by Application
    • 2.1.3.Gene Delivery Technologies Market Snippet by Method
    • 2.1.4.Gene Delivery Technologies Market Snippet by Country
    • 2.1.5.Gene Delivery Technologies Market Snippet by Region
  • 2.2.Competitive Insights

3.Gene Delivery Technologies Key Market Trends

  • 3.1.Gene Delivery Technologies Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Gene Delivery Technologies Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Gene Delivery Technologies Market Opportunities
  • 3.4.Gene Delivery Technologies Market Future Trends

4.Gene Delivery Technologies Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Gene Delivery Technologies Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Gene Delivery Technologies Market Landscape

  • 6.1.Gene Delivery Technologies Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Gene Delivery Technologies Market - By Mode

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Mode, 2023 & 2032 (%)
    • 7.1.2.Biological
      • 7.1.2.1.Adenovirus
      • 7.1.2.2.Retrovirus
      • 7.1.2.3.AAV
      • 7.1.2.4.Lentivirus
      • 7.1.2.5.Other viruses
      • 7.1.2.6.Non-viral
    • 7.1.3.Chemical
    • 7.1.4.Physical

8.Gene Delivery Technologies Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Gene Therapy
    • 8.1.3.Cell Therapy
    • 8.1.4.Vaccines
    • 8.1.5.Research

9.Gene Delivery Technologies Market - By Method

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Method, 2023 & 2032 (%)
    • 9.1.2.Ex vivo
    • 9.1.3.In vivo
    • 9.1.4.In vitro

10.Gene Delivery Technologies Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Gene Delivery Technologies Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Gene Delivery Technologies Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Gene Delivery Technologies Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Gene Delivery Technologies Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Gene Delivery Technologies Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Gene Delivery Technologies Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.QIAGEN
    • 11.2.2.Vectalys
    • 11.2.3.Horizon Discovery Group Co.
    • 11.2.4.OriGene Technologies, Inc.
    • 11.2.5.Oxford Biomedica
    • 11.2.6.SignaGen Laboratories
    • 11.2.7.Thermo Fisher Scientific, Inc.
    • 11.2.8.Takara Bio Inc.
    • 11.2.9.Bio-Rad Laboratories, Inc.
    • 11.2.10.System Biosciences llc
    • 11.2.11.Hoffmann-La Roche AG
    • 11.2.12.Promega Corporation
    • 11.2.13.Sirion-Biotech GmbH
    • 11.2.14.Catalent Inc.

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Gene Delivery Technologies Market: Mode Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Mode
  • TABLE Global Gene Delivery Technologies Market, by Mode 2019-2032 (USD Million)
  • TABLE Gene Delivery Technologies Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Gene Delivery Technologies Market, by Application 2019-2032 (USD Million)
  • TABLE Gene Delivery Technologies Market: MethodSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Method
  • TABLE Global Gene Delivery Technologies Market, by Method2019-2032 (USD Million)
  • TABLE Gene Delivery Technologies Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Gene Delivery Technologies Market, by Region 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)